HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Gastroenterology
Meta-analysis
Meta-analysis finds R1 vascular margin acceptable for HCC but not CLM in minimally invasive liver surgery
Tumor margin choice matters differently for liver cancer types
This meta-analysis of 839 patients undergoing minimally invasive liver surgery found that R1 vascular margin (R1v) hepatectomy yields local …
For liver cancer, leaving a narrow margin is safe. For colorectal metastases, it raises recurrence risk.
May 1, 2026
Oncology
Cohort
SBRT with ≥70 Gy BED10 for colorectal liver metastases shows 74.5% 1-year FFLP
Can a higher radiation dose improve tumor control in liver metastases?
This retrospective cohort study of 116 patients with colorectal liver metastases treated with stereotactic body radiation therapy (SBRT) fou…
For liver cancer spread from colorectal cancer, higher radiation doses to tumors significantly lower the risk of regrowth, while multiple tu…
Frontiers
Apr 19, 2026
Oncology
Meta-analysis
Minimally invasive surgical thermal ablation shows improved technical success and safety in liver malignancy patients.
Minimally invasive surgery offers safe, effective treatment for liver cancer tumors
This systematic review and meta-analysis evaluated 3983 patients with hepatocellular carcinoma or colorectal liver metastases treated with m…
Minimally invasive surgery safely destroys liver cancer tumors with just 1% failure rate and 0.25% death risk for patients who can't have fu…
Apr 14, 2026